Etex wins CE Mark for bone substitute materials

According to Etex, Beta-bsm and Gamma-bsm are next generation bone substitute materials based on the company’s nanocrystalline calcium phosphate technology. This hard-setting nanocrystalline technology provides the optimal osteoconductive scaffold for new bone growth that is remodeled into bone over time, the company said.

Offered in an injectable paste or moldable putty format, Beta-bsm and Gamma-bsm provide the surgeon the flexibility to adapt to specific patient needs, the company added.

Brian Ennis, CEO of Etex, said: We are excited to continue the global expansion and distribution of our nanocrystalline calcium phosphate platform, now offering European surgeons bone graft substitutes with enhanced performance including faster setting times, higher compressive strength, and user-friendly mixing and delivery systems. Our European distribution network is rapidly expanding with initiatives in all major markets.

Etex has expertise in developing and manufacturing calcium phosphate based materials for osteobiologic applications. a-BSM Bone Substitute Material was the first product to be commercialized by Etex. Other products of Etex include bone graft substitutes suitable for reconstruction of skeletal defects, carrier formulations for recombinant human Bone Morphogenic Protein-2 (rhBMP-2) for various orthopaedic and spine indications and resorbable orthopaedic implants.